Vinod Labhasetwar

Active 1995–2024

62
Papers
22,045
Citations
54
h-index
62
i10-index

Citations

Citations per year for Vinod Labhasetwar1996: 5 citations1997: 10 citations1998: 24 citations1999: 17 citations2000: 17 citations2001: 17 citations2002: 39 citations2003: 94 citations2004: 101 citations2005: 170 citations2006: 201 citations2007: 247 citations2008: 292 citations2009: 388 citations2010: 319 citations2011: 336 citations2012: 248 citations2013: 257 citations2014: 271 citations2015: 212 citations2016: 230 citations2017: 174 citations2018: 147 citations2019: 566 citations2020: 573 citations2021: 468 citations2022: 399 citations2023: 280 citations2024: 402 citations2025: 183 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,458 citing papers, 20.1% of this breakdownChina: 955 citing papers, 13.1% of this breakdownIndia: 655 citing papers, 9% of this breakdownUnited Kingdom: 262 citing papers, 3.6% of this breakdownGermany: 231 citing papers, 3.2% of this breakdownIran: 230 citing papers, 3.1% of this breakdownSouth Korea: 216 citing papers, 3% of this breakdownSpain: 203 citing papers, 2.8% of this breakdownItaly: 201 citing papers, 2.8% of this breakdownAustralia: 183 citing papers, 2.5% of this breakdownSaudi Arabia: 173 citing papers, 2.4% of this breakdownFrance: 172 citing papers, 2.4% of this breakdown
0%20.1%Other 32%

Fields

  • Materials Science27.8%
  • Biochemistry, Genetics and Molecular Biology22%
  • Medicine16.8%
  • Pharmacology, Toxicology and Pharmaceutics14%
  • Engineering7.4%
  • Immunology and Microbiology3.6%
  • Other8.4%

Topics

  • Nanoparticle-Based Drug Delivery11.2%
  • Advanced Drug Delivery Systems7.6%
  • RNA Interference and Gene Delivery7.1%
  • Advanced biosensing and bioanalysis techniques3.2%
  • Nanoplatforms for cancer theranostics2.9%
  • Graphene and Nanomaterials Applications2.1%
  • Other65.9%

Coauthors

All papers

Open in search
  1. Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation

    Authors: , , , , , - Antioxidants 2022 cited by 227

  2. Biodegradable nanoparticles for drug and gene delivery to cells and tissue

    Authors: , - Advanced Drug Delivery Reviews 2003 cited by 3,336

  3. Highly cited research articles in Journal of Controlled Release: Commentaries and perspectives by authors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gaylen M. Zentner, Hyesung Kim, Hyuk Sang Yoo, Masamichi Nakayama, Teruo Okano, Zi‐Xian Liao, Er‐Yuan Chuang, Chun‐Wen Hsiao, Hsing‐Wen Sung, Horacio Cabral, Kazunori Kataoka, Praful R. Nair, Dennis E. Discher, Samir Mitragotri - Journal of Controlled Release 2014 cited by 787

  4. Nanotech approaches to drug delivery and imaging

    Authors: , - Drug Discovery Today 2003 cited by 1,173

  5. Nanoparticles with antioxidant enzymes protect injured spinal cord from neuronal cell apoptosis by attenuating mitochondrial dysfunction

    Authors: , , , , - Journal of Controlled Release 2019 cited by 127

  6. Rapid endo‐lysosomal escape of poly(DL‐lactide‐ co glycolide) nanoparticles: implications for drug and gene delivery

    Authors: , , , , - The FASEB Journal 2002 cited by 1,040

  7. Residual polyvinyl alcohol associated with poly (d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake

    Authors: , , , - Journal of Controlled Release 2002 cited by 964

  8. Biophysical Interactions with Model Lipid Membranes: Applications in Drug Discovery and Drug Delivery

    Authors: , , - Molecular Pharmaceutics 2009 cited by 548

  9. Catalytic antioxidant nanoparticles mitigate secondary injury progression and promote functional recovery in spinal cord injury model

    Authors: , , , , , - Journal of Controlled Release 2023 cited by 42

  10. Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size

    Authors: , , , - Pharmaceutical Research 1996 cited by 935

  11. Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles

    Authors: , , - Advanced Drug Delivery Reviews 2013 cited by 278

  12. Nanoparticle-mediated catalase delivery protects human neurons from oxidative stress

    Authors: , , , - Cell Death and Disease 2013 cited by 162

  13. Solid‐state Solubility Influences Encapsulation and Release of Hydrophobic Drugs from PLGA/PLA Nanoparticles

    Authors: , , , , - Journal of Pharmaceutical Sciences 2004 cited by 318

  14. Nanoparticles: Cellular Uptake and Cytotoxicity

    Authors: , , - Advances in experimental medicine and biology 2014 cited by 178

  15. Drug Resistance in Breast Cancer Cells: Biophysical Characterization of and Doxorubicin Interactions with Membrane Lipids

    Authors: , , , , , - Molecular Pharmaceutics 2010 cited by 159

  16. The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent

    Authors: , , , , - Pharmaceutical Research 1997 cited by 853

  17. Nanosystems in Drug Targeting: Opportunities and Challenges

    Authors: , , - Current Nanoscience 2005 cited by 412

  18. Biodistribution, Clearance, and Biocompatibility of Iron Oxide Magnetic Nanoparticles in Rats

    Authors: , , , , - Molecular Pharmaceutics 2008 cited by 701

  19. Biodegradable nanoparticles for cytosolic delivery of therapeutics☆

    Authors: , - Advanced Drug Delivery Reviews 2007 cited by 530

  20. Nanoparticle‐mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia‐reperfusion injury

    Authors: , - The FASEB Journal 2009 cited by 263

  21. Characterization of nanoparticle uptake by endothelial cells

    Authors: , - International Journal of Pharmaceutics 2002 cited by 517

  22. 3-D Tumor Model forIn VitroEvaluation of Anticancer Drugs

    Authors: , , , , , , , - Molecular Pharmaceutics 2008 cited by 291

  23. Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury

    Authors: , , , - Journal of Controlled Release 2015 cited by 187

  24. Tissue plasminogen activator followed by antioxidant-loaded nanoparticle delivery promotes activation/mobilization of progenitor cells in infarcted rat brain

    Authors: , , , , , - Biomaterials 2015 cited by 85